Global pharmaceutical company Eli Lilly (NYSE:LLY) will be reporting earnings this Thursday before the bell. Here’s what ...

Eris Lifesciences is using its growing insulin business to position itself as a serious contender in India’s fast-expanding ...

A contract company for a fiber optics provider has hit a water line, forcing Lilly Grove Water Supply to issue a boil-water ...

(Reuters) -The U.S. Food and Drug Administration on Tuesday approved Ajovy, an injection made by Israeli drugmaker Teva ...

Trump is pushing drug companies to lower their prices, but experts cast doubt on how effective this endeavor will prove.

Eli Lilly's stock is lagging the S&P 500 since April, potentially allowing a catch-up trade if results impress. Medicare may ...

The Trump administration is planning to pilot covering weight loss drugs. A longtime healthcare exec moves to a strategic advisory role at General Catalyst.

Lawsuits from at least 26 patients have been filed in Marion County against Eli Lilly and Co. for its marketing of the drugs ...

Amgen Inc. boosted its 2025 guidance after quarterly results beat Wall Street’s estimates on the back of strong sales from older medicines such as the cholesterol-lowering drug Repatha.

The market is driving prices on GLP-1 drugs down, and an added benefit is lower spending on food.

Pfizer CEO says drugmakers ‘are all ready to roll up their sleeves and execute’ as president demands more direct-to-consumer options ...

Findings from a Phase III study highlight the demonstrated action of donanemab-azbt (brand name Kisunla) in slowing the ...